Pin1 and secondary hyperparathyroidism of chronic kidney disease: Gene polymorphisms and protein levels

11Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 (Pin1) is a key regulator of PTH mRNA stability. Secondary hyperparathyroidism (SHPT), which is characterized by elevated serum PTH levels, is a common complication of CKD. We investigated the possible associations between CKD with SHPT (CKD SHPT) and single-nucleotide polymorphisms of the Pin1 gene and compared the levels of the Pin1 protein in the CKD SHPT patients with those of the controls. Methods: The study group included 251 CKD SHPT patients and 61 controls. One putative functional SNP (single nucleotide polymorphism) in the Pin1 promoter (rs2233679C>T: c.−667C>T) is the main object. Genotyping was performed on purified DNA using polymerase chain reaction-restriction (PCR) and restriction fragment length polymorphisms (RFLP). The levels of Pin1 were measured in serum using an enzyme-linked immunosorbent assay. Results: Genotyping showed that CT+TT in the Pin1 promoter was significantly more common in the CKD SHPT group than in the control group (p

Cite

CITATION STYLE

APA

Zhao, Y., Zhang, L. L., Ding, F. X., Cao, P., Qi, Y. Y., & Wang, J. (2017). Pin1 and secondary hyperparathyroidism of chronic kidney disease: Gene polymorphisms and protein levels. Renal Failure, 39(1), 159–165. https://doi.org/10.1080/0886022X.2016.1256310

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free